 | • レポートコード：MRC2304G167 • 出版社/出版日：Mordor Intelligence / 2023年2月 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：食品 |
| Single User | ￥712,500 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,312,500 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本調査資料では、世界のEPA＆DHA市場規模が、昨年1,626.10百万ドルとなり、今後5年の間にCAGR6.76％で拡大すると展望しています。本資料は、EPA＆DHAの世界市場について調査を行い、市場の現状や動向をまとめています。イントロダクション、調査手法、エグゼクティブサマリー、市場動向、種類別（エイコサペンタエン酸（EPA）、ドコサヘキサエン酸（DHA））分析、由来別（魚油、藻油、オキアミ油、その他）分析、用途別（乳児用調製乳、栄養補助食品、栄養強化食品・飲料、医薬品、その他）分析、地域別（アメリカ、メキシコ、カナダ、スペイン、イギリス、ドイツ、フランス、ロシア、イタリア、中国、日本、インド、オーストラリア、ブラジル、アルゼンチン、UAE、南アフリカ）分析、競争状況、市場機会・将来の動向など、以下の項目を掲載しています。また、主要参入企業として、Koninklijke DSM NV、KD Pharma Group、The Archer Daniels Midland Company、Corbion NV、Novasep Holding SAS、Neptune Wellness Solutions、BASF SE、Omega Protein Corporation、Croda International PLC、Novotech Nutraceuticals、Polaris SAなどの情報を含んでいます。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界のEPA＆DHA市場規模：種類別 - エイコサペンタエン酸（EPA）の市場規模 - ドコサヘキサエン酸（DHA）の市場規模 ・世界のEPA＆DHA市場規模：由来別 - 魚油における市場規模 - 藻油における市場規模 - オキアミ油における市場規模 - その他における市場規模 ・世界のEPA＆DHA市場規模：用途別 - 乳児用調製乳における市場規模 - 栄養補助食品における市場規模 - 栄養強化食品・飲料における市場規模 - 医薬品における市場規模 - その他における市場規模 ・世界のEPA＆DHA市場規模：地域別 - 北米のEPA＆DHA市場規模 アメリカのEPA＆DHA市場規模 カナダのEPA＆DHA市場規模 メキシコのEPA＆DHA市場規模 … - ヨーロッパのEPA＆DHA市場規模 イギリスのEPA＆DHA市場規模 フランスのEPA＆DHA市場規模 イタリアのEPA＆DHA市場規模 … - アジア太平洋のEPA＆DHA市場規模 中国のEPA＆DHA市場規模 インドのEPA＆DHA市場規模 日本のEPA＆DHA市場規模 … - 南米/中東のEPA＆DHA市場規模 ブラジルのEPA＆DHA市場規模 アルゼンチンのEPA＆DHA市場規模 南アフリカのEPA＆DHA市場規模 … - その他地域のEPA＆DHA市場規模 ・競争状況 ・市場機会・将来の動向 |
The EPA and DHA Market was valued at USD 1,626.10 million last year and is projected to register a CAGR of 6.76% over the next five years.
Globally, EPA and DHA have been gaining importance and are becoming a part of consumers’ daily diets. The key reasons for this change are primarily the increased prevalence of lifestyle diseases and people taking preventive healthcare measures. Moreover, the emerging applications of EPA and DHA in food, dietary supplements, and clinical nutrition have further stimulated the market’s growth. New sources of EPA and DHA have been gaining prominence recently. Microalgae, a source rich in omega-3 and beta-carotene, has gained immense popularity among manufacturers as a sustainable source of food and fuel.
Algae omega ingredients are key in driving the overall market due to the growing demand for algae omega in infant food fortification. They provide benefits similar to fish oil but have no off-putting odor or taste. Also, omega ingredients obtained from algae are considered more bioavailable and sustainable for production. Moreover, there has been a shift in consumer demand for dietary supplement sources in countries and regions like the United States, China, and Europe.
The consumers of supplements have been shifting away from refined anchovy oils and inclining toward omega ingredients of higher concentration. There are plenty of reasons why consumers reach for omega-3 concentrates, including the ease of delivery that the concentrates offer. Smaller capsules and soft gel sizes can deliver a dose of high concentrated omega-3, which consumers highly appreciate. This has been accelerating sales for the global omega ingredients market.
EPA & DHA Market Trends
Increasing Application of Docosahexaenoic Acid (DHA)
The DHA segment is driven by its growing demand and incorporation in infant formulae and nutritional products targeting children’s health. It is an essential building block for the growth and maturation of an infant’s brain and retina. It is mostly obtained from fish and algae oils. Additionally, it is extensively used in fortified foods and dietary supplements. It is mainly used for treating Type 2 diabetes, coronary artery disease (CAD), dementia, and attention deficit hyperactivity disorder (ADHD). The healthy aging-related benefits of DHA have also led to its successful utilization in geriatric nutrition products.
Furthermore, an increasing number of product launches worldwide favors the industry’s growth. Additionally, the sector is growing due to increasing product launches worldwide. Global firms, such as Polaris, seek to improve their product offerings in the fish-free omega 3. As a result, it introduced Omegavie DHA 800 microalgae oil in June 2021, guaranteeing at least 800 mg/g of DHA. The ingredient is non-GMO, allergen-free, and guaranteed to be toxin-free, making it safe for vegetarians and vegans. As a result, all the current consumer demand is being targeted.
Asia-Pacific Holds a Significant Share in the EPA and DHA Market
Asia-Pacific has been leading the market studied, owing to the high consolidated production and consumption in countries like China and Japan. Consumers in this region tend to source omega-3 majorly from fish-rich diets rather than algae-based products. Thus, food manufacturers do not find it worth increasing the production cost by incorporating expensive algal omega-3 ingredients to replace fish-extracted ingredients. Moreover, to cater to the demand for DHA and EPA ingredients in India, in September 2021, the Indian Food Safety Authority gave Evonik clearance to import and distribute AvailOm in India to accelerate the roll-out of its omega-3 solution.
There has also been a growing demand among children to fulfill their key nutritional requirements due to the increasing awareness about the crucial role of EPA and DHA on brain development and other vital functions. To cater to the demand, major market players are introducing new product innovations to maintain the necessary nutritional intake of the young ones. For instance, in October 2021, Danone India, with its mission ‘to bring health through food,’ launched fortified beverages AptaGrow for children. AptaGrow includes prebiotics and DHA for the physical and cognitive development of children.
EPA & DHA Market Competitor Analysis
The EPA and DHA market is moderately concentrated by a few players, such as BASF SE, Croda International PLC, and Koninklijke DSM NV. Many small companies started commercial production of EPA and DHA and were acquired by larger players as a competitive strategy. They are also focussing on investment in R&D to compete in the growing market. Moreover, various global companies have become active in the EPA and DHA market during the last few years with tactical acquisitions, mergers, and partnerships.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Drivers
4.2 Market Restraints
4.3 Porter’s Five Forces Analysis
4.3.1 Bargaining Power of Suppliers
4.3.2 Bargaining Power of Buyers
4.3.3 Threat of New Entrants
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Type
5.1.1 Eicosapentaenoic Acid (EPA)
5.1.2 Docosahexaenoic Acid (DHA)
5.2 Source
5.2.1 Fish Oil
5.2.2 Algae Oil
5.2.3 Krill Oil
5.2.4 Other Sources
5.3 Application
5.3.1 Infant Formulae
5.3.2 Dietary Supplements
5.3.3 Fortified Food and Beverages
5.3.4 Pharmaceuticals
5.3.5 Other Applications
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Mexico
5.4.1.3 Canada
5.4.1.4 Rest of North America
5.4.2 Europe
5.4.2.1 Spain
5.4.2.2 United Kingdom
5.4.2.3 Germany
5.4.2.4 France
5.4.2.5 Russia
5.4.2.6 Italy
5.4.2.7 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 Rest of Asia-Pacific
5.4.4 South America
5.4.4.1 Brazil
5.4.4.2 Argentina
5.4.4.3 Rest of South America
5.4.5 Middle East
5.4.5.1 United Arab Emirates
5.4.5.2 South Africa
5.4.5.3 Rest of Middle East
6 COMPETITIVE LANDSCAPE
6.1 Strategies Adopted by Players
6.2 Most Active Companies
6.3 Company Profiles
6.3.1 Koninklijke DSM NV
6.3.2 KD Pharma Group
6.3.3 The Archer Daniels Midland Company
6.3.4 Corbion NV
6.3.5 Novasep Holding SAS
6.3.6 Neptune Wellness Solutions
6.3.7 BASF SE
6.3.8 Omega Protein Corporation
6.3.9 Croda International PLC
6.3.10 Novotech Nutraceuticals
6.3.11 Polaris SA
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
8 DISCLAIMER